HIGHLIGHTS
- who: Ji Hye Yang and collaborators from the College of Korean Medicine, Daegu Haany University, Gyeongsan, Gyeongsangbuk-do, Korea have published the article: Neoagarooligosaccharide Protects against Hepatic Fibrosis via Inhibition of TGF-/Smad Signaling Pathway, in the Journal: (JOURNAL) of 22/Dec/2015
- what: The authors show that NAOs attenuate hepatic fibrosis both in_vitro and in_vivo.
- how: The results showed that the CCl4 -treated mice had large amounts of collagen deposition in the fibrotic septa between nodules. One-way analysis of variance (ANOVA) was used to determine the significance of the differences between . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.